Zydus Lifesciences Share Hits 52-Week High on USFDA Approval for Osteoporosis Drug
Shares of Zydus Lifesciences hit a 52-week high in morning trade on April 19 after the company said it had received final approval from the...
Tag : Zydus Lifesciences
Zydus Lifesciences Shares Rise After USFDA Approves Tofacitinib Tablets
Shares of Zydus Lifesciences were trading in the early hours of March 22, after the company’s subsidiary received USFDA approval for tofacitinib tablets. Zydus Pharmaceuticals...
Back-to-Back USFDA Approvals Boost Zydus Lifesciences, Shares Hit 8-Month High
Zydus Lifesciences’ drug hit an eight-month high following a string of US regulatory approvals. The stock hit Rs 426 on the NSE on October 7...
Zydus Lifesciences’ Generic Drug Mirabegron for Overactive Bladder Gets USFDA Nod
On Monday, Zydus Lifesciences said it received the USFDA’s (United States Food and Drug Administration) final nod to market its version of Mirabegron extended-release tablets...
Zydus Receives USFDA Approval for Generic Antacid
On Monday, Zydus Lifesciences said that it had received final approval from US health regulators to market its antacid famotidine tablets in the US market....
Zydus Publishes Phase-3 Clinical Trial Data of ZyCoV-D
Zydus Lifesciences announced that the safety and efficacy analysis data from the phase-III clinical trial of its Covid-19 vaccine ZyCoV-D has been examined and published...
Zydus to Acquire US-based BridgeBio Pharma
Zydus Lifesciences said its subsidiary had acquired US-based BridgeBio Pharma. Sentynl Therapeutics, a subsidiary of Zydus Lifesciences and BridgeBio Pharma, have done an asset purchase...
Zydus Gets DCGI Nod For Drug to Treat Anaemia Linked With Kidney Disease
Zydus Lifesciences announced that it had received approval from the Drug Controller General of India (DCGI) for Oxemia, an oral treatment for anaemia linked with...